Kate Haviland, Chief Operating Officer at Blueprint Medicines Corp (BPMC), sold 15,526 shares at $85.16 ($1.3M) on 2020-01-10, disclosed to the SEC on 2020-01-14.
Open-market sale of $1.3M BPMC by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.16 | 7,763 | $661K | 50.0% |
| 2 | $85.16 | 7,763 | $661K | 50.0% |
| Total | $85.16 avg | 15,526 | $1.3M | 100% |
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |